REPORTS

These publications are the output of RSPCA-led expert working groups comprising scientists from academia and industry, veterinarians, animal technologists and other relevant stakeholders. Some cover broad issues associated with avoiding or reducing ‘severe’ suffering such as refinement, welfare assessment and the implementation of humane endpoints, whilst others provide guidance relating to specific models and procedures that have the potential to cause ‘severe’ suffering.
Avoiding mortality

Avoiding mortality

Hawkins et al. (2019)

Avoiding mortality in animal research and testing.
ISBN: 978-0-901098-17-7A

Experimental Autoimmune Encephalomyelitis (EAE)

Experimental Autoimmune Encephalomyelitis (EAE)

Wolfensohn et al. (2013)

Reducing suffering in experimental autoimmune encephalomyelitis (EAE).
Journal of Pharmacological &
Toxicological Methods 67, 169-176

Rheumatoid arthritis

Rheumatoid arthritis

Hawkins et al. (2015)

Applying refinement to the use of mice and rats in rheumatoid arthritis research.
Inflammopharmacology 23, 131-150

Seizures, convulsions and epilepsy

Seizures, convulsions and epilepsy

Wolfensohn et al. (2013)

Reducing suffering in animal models and procedures involving seizures,
convulsions and epilepsy.
Journal of Pharmacological &
Toxicological Methods 67, 9-15

Avoiding mortality

Sepsis

Lilley et al. (2015)

Refinement of animal models of sepsis and septic shock.
Shock 43, 304-316

Spinal cord injury

Spinal cord injury

Lilley et al. (2020)

Refining rodent models of spinal cord injury.
Experimental Neurology 328, 113273

RELEVANT REPORTS BY OTHER ORGANISATIONS

Cancer research

Workman P et al. (2010)

Guidelines for the welfare and use of animals in cancer research.
British Journal of Cancer 102, 1555–1577 https://doi.org/10.1038/sj.bjc.6605642

Cardiovascular research

Emerson (2010)

Refinement, reduction and replacement approaches to in vivo cardiovascular research.
British Journal of Pharmacology 161, 749-754

Epilepsy

Modebadze et al. (2016)

A low mortality, high morbidity Reduced Intensity Status Epilepticus (RISE) model of epilepsy and epileptogenesis in the rat.
PLoS ONE 11(2), e0147265 doi:10.1371/journal.pone.0147265

Epilepsy and seizures

Lidster et al. (2016)

Opportunities for improving animal welfare in rodent models of epilepsy and seizures.
Journal of Neuroscience Methods 260, 2-25

Ischaemic stroke

Percie du Sert N et al. (2017)

The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments).
Journal of Cerebral Blood Flow and Metabolism 37(11), 3488-3517 doi:10.1177/0271678X17709185

Liver fibrosis models

Probert PME et al. (2014)

A reversible model for periportal fibrosis and a refined alternative to bile duct ligation.
Toxicology Research 3, 98-109
doi: 10.1039/C3TX50069A

Neuropathic pain

Percie du Sert & Rice (2014)

Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.
British Journal of Pharmacology 161, 749-754

Vaccine potency testing

Hendriksen (2009)

Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement.
Expert Review of Vaccines 8, 313-322

Vaccine studies using NHPs

Prescott et al. (2021)

Opportunities for refinement of non-human primate vaccine studies.
Vaccines 9, 284

AVOIDING AND REDUCING SEVERE SUFFERING

Avoiding and reducing severe suffering helps to fulfil legal requirements, reduce ethical concerns and improve scientific quality – this website will help you to achieve this.

Practical ways to reduce or avoid severe suffering include: